Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 29;13(4):332-336.
doi: 10.1136/flgastro-2021-101886. eCollection 2022.

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)

Affiliations

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)

Paul N Brennan et al. Frontline Gastroenterol. .

Abstract

The European Association for the Study of the Liver has produced extensive guidelines for the investigation and management of drug-induced liver injury. Here, we provide a commentary and overview of some of the principle disease investigations and management that arise from these guideline recommendations.

Keywords: drug induced hepatotoxicity; drug induced liver injury; drug metabolism; drug toxicity.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JFD has received research grants and lecture honoraria from MSD, Abbvie and Gilead.

Figures

Figure 1
Figure 1
Suggested approach to presentation of drug-induced liver injury (DILI). ANA, antinuclear antibody; BC, Budd-Chiari syndrome; CMV, cytomegalovirus; EBV, Epstein-Barr virus; HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HEV, hepatitis E virus; HSV, hepes simplex virus; HCC, hepatocellular carcinoma; LKM, liver microsomal antibody; NRH, nodular regenerative hyperplasia; PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; PVT, portal vein thrombosis; SMA, smooth muscle antibody; USS, ultransound scan; VZV, varicella zoster virus.

References

    1. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, Clinical Practice Guideline Panel: Chair:, Panel members, et al. . EASL clinical practice guidelines: drug-induced liver injury. J Hepatol 2019;70:1222–61. 10.1016/j.jhep.2019.02.014 - DOI - PubMed
    1. Björnsson ES, Bergmann OM, Björnsson HK, et al. . Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013;144:1419–25. 10.1053/j.gastro.2013.02.006 - DOI - PubMed
    1. Navarro VJ, Barnhart H, Bonkovsky HL, et al. . Liver injury from herbals and dietary supplements in the U.S. drug-induced liver injury network. Hepatology 2014;60:1399–408. 10.1002/hep.27317 - DOI - PMC - PubMed
    1. Bessone F, García-Cortés M, Medina-Caliz I, et al. . Herbal and dietary Supplements-Induced liver injury in Latin America: experience from the Latindili network. Clin Gastroenterol Hepatol 2021. 10.1016/j.cgh.2021.01.011. [Epub ahead of print: 09 Jan 2021]. - DOI - PubMed
    1. Douros A, Bronder E, Andersohn F, et al. . Herb-induced liver injury in the Berlin case-control surveillance study. Int J Mol Sci 2016;17. 10.3390/ijms17010114. [Epub ahead of print: 15 Jan 2016]. - DOI - PMC - PubMed

LinkOut - more resources